Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Substance Abuse Technologies to restructure:

This article was originally published in Clinica

Executive Summary

Substance Abuse Technologies will continue its operations while attempting to restructure, having filed for Chapter 11 bankruptcy protection. The beleaguered company has received loans from two of its largest shareholders. However, a SAT subsidiary, US Drug Testing, is suspending development of its saliva-based drugs-of-abuse and alcohol testing devices. It says attempts to seek alternative funding when SAT failed have been unsuccessful.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel